How much impact does India’s COVID epidemic have on the global pharmaceutical industry?

The number of people infected with cowid COIVD in India is the fastest growing in 2021. The number of confirmed cases has exceeded 300000 cases, which has repeatedly set the highest record of new cases in a single country in a single day.

The impact of the epidemic on the industry is obvious. In 2020, due to the epidemic, many Indian textile orders have been transferred to China, which leads to the phenomenon of order explosion in related industries. Now that COVID-19 in India is raging again, and the situation is getting out of control, will there be any risk of shutting down production in India’s pharmaceutical manufacturing industry?

1. The epidemic has caused market concerns about whether India’s pharmaceutical industry will be affected and whether the global pharmaceutical industry chain will be affected.

2. India’s pharmaceutical industry plays an important role in the global industrial chain. On the one hand, nearly 20% of the generic drugs are produced in the world, and exported to more than 200 countries, of which more than 60% are exported to the United States, Europe, Russia and other countries; On the other hand, India is also an important API production base in the world.

The relationship between Indian pharmaceutical industry and Chinese pharmaceutical industry is generally upstream and downstream. Although China has become the largest producer of pharmaceutical raw materials in the world by scale effect and infrastructure capacity, China has been the upstream of Indian generic pharmaceutical, a rare player in the industrial chain, which provides raw materials for Indian generic.

Because of the impact of the epidemic on India’s generic drug industry, China also began to enter the generic drug industry in order to reduce its impact on China’s market demand.

1. In May last year, some Chinese api enterprises began to start adding code generic pharmaceutical market after resuming work and resuming, such as four API companies and, before and after that, they launched refinancing and expanding production plans to add code generic pharmaceutical.

2. The top level is also working on the reform of the generic industry: through the planned distribution mode of purchasing with quantity, the growth of local generic enterprises is further encouraged.